Hans Lofgren – författare

In an age of shifting boundaries between state and civil society, consumer groups are potentially drivers of democratization in the health domain. The expert contributors explore how their activities bring new dynamics to relations between service providers, the medical profession, government agencies, and other policy actors. This book is unique in comprehensively analyzing the opportunities and dilemmas of this type of activism, including ambiguous partnerships between consumer groups and stakeholders such as the pharmaceutical industry. These themes are explored within an internationally comparative framework, with case studies from various countries.

Students and researchers in the fields of health policy and sociology, public policy and social movements will find this relevant and path-breaking book enlightening. It will also prove invaluable for participants and activists in patient and health consumer organizations.

Contributors include: K. Adams, W. Armstrong, R. Baggott, R. Bal, S. Barraclough, G. Braunegger-Kallinger, J. Church, D. Delnoij, R. Edwards, R. Forster, M. Fox, B. Fredericks, J. Geissler, P.C. John, K. Jones, M. Koivusalo, K. Krajic, A. Lambertson, M. Leahy, D. Legge, H. Lofgren, T. Milewa, C. Nunez Daw, O. O''Donovan, K.-L. Phua, A. Schipaanboord, J. Tritter, D. Truong, P. Vaillancourt Rosenau, A. Vitry

The book studies the pharmaceutical industry of India. It is one of the most successful stories of economic expansion and improvements in public health. Indian firms have made access to quality medicines possible and affordable in many developing countries. Indian pharmaceuticals are also exported on a large scale to the United States and other highly regulated markets. A wave of mergers, acquisitions and tie-ups point to growing integration between Indian firms and global pharma multinationals.

Please note: Taylor & Francis does not sell or distribute the Hardback in India, Pakistan, Nepal, Bhutan, Bangladesh and Sri Lanka